We're pleased to feature Cristin Berkey in this episode of Wolf Greenfield's Alumni Spotlight series. Cristin was an associate at Wolf Greenfield from 2017-2019.
Cristin currently serves as Senior Director of Intellectual Property and Contracts at Abata Therapeutics. Abata translates the biology of regulatory T cells (Tregs) into transformational medicines for patients with progressive multiple sclerosis and other serious autoimmune and inflammatory diseases.
Here are some highlights from Cristin Berkey's turn in the Alumni Spotlight on IP Talk with Wolf Greenfield.
- 00:50 - Cristin's responsibility for managing IP strategy at Abata Therapeutics
- 03:01 - An overview of T cells and their potential
- 04:53 - The difference between being an in-house attorney and working at a law firm
- 06:08 - Cristin's favorite Wolf Greenfield memory
- 06:58 - Favorite place to get away
- 07:22 - Light, heartwarming shows are a nice way to relax
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.